DT&CRO CO., Ltd. Logo

DT&CRO CO., Ltd.

A full-service CRO providing non-clinical and clinical studies for various industries.

383930 | KO

Overview

Corporate Details

ISIN(s):
KR7383930005
LEI:
Country:
South Korea
Address:
경기도 용인시 처인구 백령로20번길 28 나동 2, 3, 4층(유방동), 용인시

Description

DT&CRO CO., Ltd. is a full-service Contract Research Organization (CRO) that provides a comprehensive series of commissioned studies for the biopharmaceutical, chemical, functional food, and cosmetics sectors. The company's services span the entire development lifecycle, from non-clinical research, including GLP toxicity, pharmacokinetics (PK), and efficacy tests, to clinical trials, analysis, and regulatory consulting. Specialized offerings include a full-package service for FDA IND and NDA submissions, developed in partnership with Radyus Research. DT&CRO also provides an in-house SEND (Standard for Exchange of Nonclinical Data) program to streamline FDA registration and approval. Additionally, the company offers MoPS, a proprietary IT program that enables sponsors to manage projects and communicate with specialists in real-time.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-28 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.2 KB
2025-03-20 00:00
감사보고서제출
Korean 18.4 KB
2025-03-20 00:00
사업보고서 (2024.12)
Korean 521.3 KB
2025-03-19 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-03-19 00:00
주식등의대량보유상황보고서(일반)
Korean 87.5 KB
2025-03-13 00:00
주주총회소집결의
Korean 12.3 KB
2025-03-13 00:00
주주총회집중일개최사유신고
Korean 4.8 KB
2025-03-13 00:00
주주총회소집공고
Korean 102.1 KB
2025-03-13 00:00
의결권대리행사권유참고서류
Korean 99.1 KB
2025-02-13 00:00
임원ㆍ주요주주특정증권등거래계획보고서
Korean 41.9 KB
2025-02-12 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.1 KB
2024-12-26 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.9 KB
2024-12-26 00:00
[기재정정]신규시설투자등
Korean 10.6 KB
2024-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1001.8 KB

Automate Your Workflow. Get a real-time feed of all DT&CRO CO., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DT&CRO CO., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DT&CRO CO., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.